| Name: | Q-State Biosciences, Inc. |
| Jurisdiction: | Rhode Island |
| Entity type: | Foreign Corporation |
| Status: | Revoked Entity |
| Date of Organization in Rhode Island: | 11 Dec 2020 (4 years ago) |
| Date of Dissolution: | 12 Sep 2023 (a year ago) |
| Date of Status Change: | 12 Sep 2023 (a year ago) |
| Identification Number: | 001716208 |
| Place of Formation: | DELAWARE |
| Principal Address: | 179 SIDNEY STREET, CAMBRIDGE, MA, 02139, USA |
| Purpose: | DISCOVERING AND DEVELOPING TRANSFORMATIVE TREATMENTS FOR PAIN EPILEPSY AND DISEASES OF ELECTRICALLY EXCITABLE CELLS |
| Name | Role | Address |
|---|---|---|
| CT CORPORATION SYSTEM | Agent | 450 VETERANS MEMORIAL PARKWAY SUITE 7A, EAST PROVIDENCE, RI, 02914, USA |
| Name | Role | Address |
|---|---|---|
| PAUL MEDEIROS | CEO | 1 QUINCY ADAMS ROAD BARRINGTON, RI 02806 USA |
| Name | Role | Address |
|---|---|---|
| CHRIS WATT | CFO | 179 SIDNEY STREET CAMBRIDGE, MA 02139 USA |
| Name | Role | Address |
|---|---|---|
| CHAD MARTINSON | DIRECTOR | 2877 PARADISE ROAD, UNIT 6021 LAS VEGAS, NV 89109 USA |
| Number | Name | File Date |
|---|---|---|
| 202341545530 | Revocation Certificate For Failure to File the Annual Report for the Year | 2023-09-12 |
| 202338227540 | Revocation Notice For Failure to File An Annual Report | 2023-06-19 |
| 202211089890 | Annual Report | 2022-02-17 |
| 202195967290 | Annual Report | 2021-04-26 |
| 202079726160 | Application for Certificate of Authority | 2020-12-11 |
Date of last update: 28 Oct 2024
Sources: Rhode Island Department of State
